Polio vaccination schedules in the United States: The rationale for change

Seminars in Pediatric Infectious Diseases

Volumn 10, Issue 4, 1999, Pages 249-257

  Yogev, R ^a   Edwards, K M ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; ORAL POLIOMYELITIS VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; CLINICAL PROTOCOL; ENDEMIC DISEASE; HUMAN; INFECTION PREVENTION; POLIOMYELITIS; TRAVEL; UNITED STATES; VACCINATION;

EID: 0032700749     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1045-1870(99)80032-6     Document Type: Article

References (64)

1. Centers for Disease Control and Prevention Poliomyelitis prevention in the United States: Introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 46 1997 1 25
2. American Academy of Pediatrics Committee on Infectious Diseases Poliomyelitis prevention: Revised recommendations for use of inactivated and live oral poliovirus vaccines Pediatrics 103 1999 171 172
3. Centers for Disease Control and Prevention Recommended childhood immunization schedule—United States, January–December 1999 MMWR 48 1999 12 16
4. Faden H Changing poliovirus vaccine policy can be controversial at best 1998 Mosby-Year Book St. Louis, MO
5. Strebel PM Sutter RW Cochi SL Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease Clin Infect Dis 14 1992 568 579
6. Robbins FC Polio-historical Plotkin SA Mortimer EA Vaccines ed 2 1994 Saunders Philadelphia 137 154
7. Modlin JF Poliovirus Mandell GL Bennett JE Dolin R Principles and Practice of Infectious Diseases ed 4 1995 Churchill Livingstone New York, NY 1613 1620
8. Cherry JD Enteroviruses: Coxsackieviruses echoviruses, and polioviruses Feigin RD Cherry JD Textbook of Pediatric Infectious Diseases ed 4 1998 Saunders Philadelphia 1787 1839
9. McBean AM Modlin JF Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine poliomyelitis immunization in the United States Pediatr Infect Dis J 6 1987 881 887
10. Salk D Eradication of poliomyelitis in the United States. II. Experience with killed poliovirus vaccine Rev Infect Dis 2 1980 243 257
11. Melnick JL Live attenuated poliovirus vaccines Plotkin SA Mortimer EA Vaccines ed 2 1994 Saunders Philadelphia 155 204
12. Institute of Medicine of the National Academy of Sciences Report of a study: An evaluation of poliomyelitis vaccine policy options 1988 National Academy Press Washington, DC
13. Centers for Disease Control Recommendations of the Immunization Practices Advisory Committee (ACIP). Poliomyelitis prevention: Enhanced-potency inactivated poliomyelitis vaccine—Supplementary statement MMWR 36 1987 795 798
14. Faden H Modlin JF Thoms ML Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: Systemic and local immune response J Infect Dis 162 1990 1291 1297
15. Faden H Poliovirus vaccination: A trilogy J Infect Dis 168 1993 25 28
16. Ogra PL Faden HS Poliovirus vaccines: Live or dead J Pediatr 108 1986 1031 1033
17. Faden H Duffy L Sun M Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines J Infect Dis 168 1993 452 454
18. Plotkin SA Inactivated polio vaccine for the United States: A missed vaccination opportunity Pediatr Infect Dis J 14 1995 835 839
19. Simoes EAF Padmini B Steinhoff MC Antibody response of infants to two doses of inactivated poliovirus vaccine of enhanced potency Am J Dis Child 139 1985 977 980
20. (suppl) Modlin JF Vaccine-related polio in the US Infections in Medicine 13 1996 S43 S52
21. Nkowane BM Wassilak SGF Orenstein WA Vaccine-associated paralytic poliomyelitis United States: 1973 through 1984 JAMA 257 1987 1335 1340
22. Strebel PM Ion-Nedelcu N Baughman MPH Intramuscular injections within 30 days of immunization with oral poliovirus vaccine—A risk factor for vaccine-associated paralytic poliomyelitis N Engl J Med 332 1995 500 506
23. Izurieta HS Sutter RW Baughman AL Vaccine-associated paralytic poliomyelitis in the United States: No evidence of elevated risk after simultaneous intramuscular injections of vaccine Pediatr Infec Dis J 14 1995 840 846
24. Centers for Disease Control and Prevention Progress toward global eradication of poliomyelitis, 1997 MMWR 47 1998 414 419
25. Centers for Disease Control Progress toward poliomyelitis eradication—India, December 1995 and January 1996 MMWR 45 1996 370 373
26. World Health Organization: Global incidence of polio in 1997. Available at http://www.who.int/gpv-surv/graphics/htmls/polcases97.htm
27. Centers for Disease Control and Prevention One thousand days until the target date for global poliomyelitis eradication MMWR 47 1998 234 239
28. Centers for Disease Control and Prevention Update: Eradication of paralytic poliomyelitis in the Americas MMWR 41 1992 681 683
29. Centers for Disease Control and Prevention Certification of poliomyelitis eradication—The Americas MMWR 43 1994 720 722
30. Centers for Disease Control Isolation of wild poliovirus type 3 among members of a religious community objecting to vaccination—Alberta, Canada, 1993 MMWR 42 1993 337 339
31. Philadelphia, PA Lederle Laboratories Orimune (poliovirus vaccine live oral trivalent) package insert 1998
32. McBean AM Thoms ML Albrecht P Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines Am J Epidemiol 128 1988 615 628
33. Modlin JF Halsey NA Thoms ML Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules J Infect Dis 175 suppl 1997 S228 S234
34. Sutter RW Patriarca PA Brogan S Outbreak of paralytic poliomyelitis in Oman: Evidence for widespreal transmission among fully vaccinated children Lancet 338 1991 715 720
35. van Niekerk AB Vries JB Baard J Outbreak of paralytic poliomyelitis in Namibia Lancet 344 1994 661 664
36. Zhaori G Sun M Ogra PL Characteristics of the immune response to poliovirus virion polypeptides after immunization with live or inactivated polio vaccines J Infect Dis 158 1988 160 165
37. Centers for Disease Control and Prevention Prolonged poliomyelitis excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis MMWR 46 1997 641 643
38. Chen RT Hausinger S Dajani AS Seroprevalence of antibody against poliovirus in inner-city preschool children: Implications for vaccination policy in the United States JAMA 275 1996 1639 1645
39. Vidor E Meschievitz C Plotkin S Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine Pediatr Infect Dis J 16 1997 312 322
40. Onorato IM Modlin JF McBean AM Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines J Infect Dis 163 1991 1 6
41. American Academy of Pediatrics Committee on Infectious Diseases Poliomyelitis prevention: Revised recommendations for use of inactivated and live oral poliovirus vaccines Pediatrics 103 1999 171 172
42. Centers for Disease Control and Prevention Recommended childhood immunization schedule—United States, 1998 MMWR 47 1998 8 12
43. Centers for Disease Control and Prevention Impact of the sequential IPV/OPV schedule on vaccination coverage levels-United States, 1997 MMWR 47 1998 1017 1019
44. Ramsay ME Begg NT Gandhi J Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines Pediatr Inject Dis J 13 1994 1117 1121
45. Goldblum N Gerichter CB Tulchinsky TH Poliomyelitis control in Israel, the West Bank and Gaza Strip: Changing strategies with the goal of eradication in an endemic area Bull World Health Organ 72 1994 783 796
46. Drucker J Poliomyelitis in France: Epidemiology and vaccination status Pediatr Infect Dis J 10 1991 967 969
47. Salk J Drucker JA Malvy D Noninfectious poliovirus vaccine Plotkin SA Mortimer EA Vaccines ed 2 1994 Saunders Philadelphia 205 227
48. Bottiger M Long-term immunity following vaccination with killed poliovirus vaccine in Sweden, a country with no circulating poliovirus Rev Infect Dis 6 suppl 1984 S548 S551
49. (abstr) Kolasa M Gisgard K Prevots R IPV or OPV: Will parents accept the new poliovirus vaccination recommendations Pediatr Res 41 1997 95A
50. Thoms ML Bodnar PZ O'Donovan JC Parenteral knowledge and choice regarding live and inactivated poliovirus vaccines Arch Pediatr Adolesc Med 151 1997 809 812
51. Ball T Serwint J Missed opportunities for vaccination and the delivery of preventive care Arch Pediatr Adolesc Med 150 1996 858 861
52. Woodin KA Rodewald LE Humiston SG Physician and parent opinions: Are children becoming pincushions from immunizations Arch Pediatr Adolesc Med 149 1995 845 849
53. American Academy Committee on Infectious Diseases Poliomyelitis prevention: Recommendations for use of inactivated poliovirus vaccine and live poliovirus vaccine Pediatrics 99 1997 300 305
54. Centers for Disease Control and Prevention Progress toward global eradication of poliomyelitis, 1996 MMWR 46 1997 579 584
55. King GE Hadler SC Simultaneous administration of childhood vaccines: An important public health policy that is safe and efficacious Pediatr Infect Dis J 13 1994 394 407
56. Dagan R Igbaria K Piglansky L Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine Pediatr Infect Dis J 16 1997 1113 1121
57. (suppl) Edwards KM Decker MD Combination vaccines consisting of acellular pertussis vaccines Pediatr Infect Dis J 16 1997 S97 S102
58. Eskola J Kayhty H Gordon LK Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations in childhood Pediatr Infect Dis J 7 1988 480 484
59. Gold R Scheifele D Barreto L Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age Pediatr Infect Dis J 13 1994 348 355
60. Halsey NA Blatter M Bader G Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine Pediatr Infect Dis J 16 1997 675 679
61. Lagos R Kotloff K Hoffenback A Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants Pediatr Infect Dis J 17 1998 294 304
62. Begue P Stagnara J Vie-Le-Sage F Immunogenicity and reactogenicity of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccines given concurrently with Haemophilus type b conjugate vaccine oral as pentavalent vaccine Pediatr Infect Dis J 16 1997 787 794
63. Ipp MM Gold R Goldbach M Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: Effect of injection site and needle length Pediatrics 83 1989 679 682
64. The Advisory Committee on Immunization Revised recommendations for routine poliomyelitis vaccination MMWR 48 1999 590